Judge Refuses To Halt Amgen-Micromet Deal


Salon Staff
March 2, 2012 12:54AM (UTC)

DOVER, Del. (AP) — A Delaware judge has refused to delay the acquisition of Micromet Inc. by Amgen Inc., the world's largest biotech company.

A tender offer in which Amgen is offering $11 per share for Micromet, a Maryland-based developer of cancer therapies, was to expire at midnight Thursday.

Advertisement:

Some Micromet shareholders challenged the proposed deal, arguing at a hearing earlier this week that Micromet's board rushed it through and did not adequately explore whether it could get a competing offer at a better price.

But in a ruling filed late Wednesday, the judge said the shareholders were not entitled to a preliminary injunction because they had not shown a reasonable likelihood that they would succeed in proving their claims.


Salon Staff

MORE FROM Salon Staff

BROWSE SALON.COM
COMPLETELY AD FREE,
FOR THE NEXT HOUR

Read Now, Pay Later - no upfront
registration for 1-Hour Access

Click Here
7-Day Access and Monthly
Subscriptions also available
No tracking or personal data collection
beyond name and email address

•••


Fearless journalism
in your inbox every day

Sign up for our free newsletter

• • •